Screener — stockrow

McKesson Corporation

MCK Healthcare · Medical Distribution · US

$1,074.06 +27.2% 1Y

Low $723.68 High $1,121.50

McKesson is a healthcare services company that gets medicines and medical supplies from manufacturers to pharmacies, hospitals, physician practices and other customers. It also provides technology, logistics and services that help healthcare businesses manage operations and help patients access their medications.

Market cap $125.0B

Revenue growth (Q) +7.57%

EPS growth (Q) +17.0%

FCF growth (Q) +32.5%

Revenue growth (next yr) +7.05%

Net margin 1.12%

ROE −190.5%

P/E 27.5×

Forward P/E 25.4×

P/FCF 18.2×

Dividend yield 0.32%

Insider ownership 0.00%

Insider buys / sells (12M) — $29.1M

Reported	FY2023	FY2024	FY2025	FY2026	TTM
Revenue	$276.7B	$309.0B	$359.1B	$403.4B	$418.8B
EPS	$25.03	$22.39	$25.72	$38.38	$38.89
Free cash flow	$4.6B	$3.6B	$5.2B	$5.4B	$6.9B
Net debt	$7.5B	$7.2B	$5.6B	$7.6B	$7.2B

Cencora, Inc.

COR Healthcare · Medical Distribution · US

$339.76 −4.02% 1Y

Low $244.82 High $377.54

Cencora sources and distributes pharmaceuticals and provides services to healthcare providers and drug manufacturers. It was founded in 2001 and is headquartered in Chesterbrook.

Market cap $64.8B

Revenue growth (Q) +5.52%

EPS growth (Q) +257.7%

FCF growth (Q) −7.81%

Revenue growth (next yr) +4.89%

Net margin 1.03%

ROE 0.00%

P/E 18.8×

Forward P/E 17.5×

P/FCF 16.7×

Dividend yield 0.71%

Insider ownership 0.46%

Insider buys / sells (12M) $2.3M $15.4M

Reported	FY2023	FY2024	FY2025	FY2026
Revenue	$262.2B	$294.0B	$321.3B	$337.4B
EPS	$8.53	$7.53	$7.96	$18.04
Free cash flow	$3.5B	$3.0B	$3.2B	$3.9B
Net debt	$2.2B	$1.3B	$3.3B	$6.4B

Cardinal Health, Inc.

CAH Healthcare · Medical Distribution · US

$267.66 +36.0% 1Y

Low $180.45 High $286.29

Cardinal Health, Inc. (CAH) is a leading global healthcare services and products company headquartered in Dublin, Ohio, United States. Founded in 1971 by Robert D. Walter, the company initially operated as a food wholesaler before transitioning into the healthcare sector.

Market cap $62.0B

Revenue growth (Q) +5.47%

EPS growth (Q) +26.5%

FCF growth (Q) +10.9%

Revenue growth (next yr) +4.53%

Net margin 0.71%

ROE −65.0%

P/E 34.5×

Forward P/E 24.5×

P/FCF 13.6×

Dividend yield 0.77%

Insider ownership 0.43%

Insider buys / sells (12M) — $61.6M

Reported	FY2023	FY2024	FY2025	FY2026	TTM
Revenue	$205.0B	$226.8B	$222.6B	$254.2B	$257.8B
EPS	$1.26	$3.45	$6.45	$7.23	$7.73
Free cash flow	$2.4B	$3.3B	$1.9B	$4.6B	$4.6B
Net debt	$625.0M	−$41.0M	$4.7B	$4.0B	$3.6B

Henry Schein, Inc.

HSIC Healthcare · Medical Distribution · US

$85.40 +18.6% 1Y

Low $68.70 High $92.18

Henry Schein supplies health care products and services to dental and medical professionals, particularly those working outside hospitals. Founded in 1932 and headquartered in Melville, New York, the company is led by CEO Frederick M. Lowery.

Market cap $9.4B

Revenue growth (Q) +3.95%

EPS growth (Q) +33.3%

FCF growth (Q) −7.09%

Revenue growth (next yr) +5.17%

Net margin 3.07%

ROE 10.7%

P/E 22.8×

Forward P/E 21.3×

P/FCF 17.0×

Dividend yield —

Insider ownership 15.3%

Insider buys / sells (12M) $0.7M $8.4M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$12.6B	$12.3B	$12.7B	$13.2B	$13.7B
EPS	$3.91	$3.16	$3.05	$3.27	$3.71
Free cash flow	$506.0M	$353.0M	$700.0M	$573.0M	$559.0M
Net debt	$929.0M	$1.9B	$1.8B	$2.2B	$2.3B

Akso Health Group Sponsored ADR

AHG Healthcare · Medical Distribution · CN

$1.30 −23.5% 1Y

Low $0.68 High $2.50

Akso Health Group Sponsored ADR (AHG) is a prominent player in the healthcare and wellness industry, with a focus on delivering innovative solutions to improve the quality of life for individuals worldwide. Founded in [insert founding year], the company has its roots in [insert founding location], where it began as a small-scale operation aimed at addressing specific healthcare needs.

Market cap $1.1B

Revenue growth (Q) +263.9%

EPS growth (Q) +71.7%

FCF growth (Q) −12,975.0%

Revenue growth (next yr) −100.0%

Net margin −61.3%

ROE 0.00%

P/E —

Forward P/E 0.0×

P/FCF —

Dividend yield —

Insider ownership 0.00%

Insider buys / sells (12M) — —

Reported	FY2023	FY2024	FY2025	FY2026
Revenue	$13.2M	$2.4M	$14.8M	$13.8M
EPS	−$0.02	−$0.20	−$0.48	$0.01
Free cash flow	−$3.3M	$1.4M	$1.0M	−$188.5M
Net debt	−$7.9M	−$85.2M	−$176.2M	$179.9K

Sector

Stockrow Weekly